DHL Boosts Pharma Logistics with CRYOPDP Buy Cryoport Partnership
DHL is acquiring CRYOPDP and partnering with Cryoport to strengthen its life sciences and healthcare supply chain, offering end-to-end specialized logistics services. The acquisition of CRYOPDP will expand DHL's capabilities in temperature-controlled logistics for the pharmaceutical and biotech industries. The collaboration with Cryoport will further enhance its offerings. This strategic move aims to provide customers with a more comprehensive and reliable solution for transporting sensitive and valuable healthcare products. The transaction is subject to regulatory approval.
